C-reactive Protein (CRP) Levels as a Predictor of Adverse Cardiovascular Events in Acute Myocardial Infarction: A...

Area of Science:

• Cardiology
• Biomarkers
• Inflammation Research

Background:

• Acute myocardial infarction (AMI) is a leading global cause of mortality.
• C-reactive protein (CRP) is an inflammatory biomarker linked to cardiac injury and systemic inflammation.
• CRP levels may predict adverse cardiovascular outcomes in AMI patients.

Purpose of the Study:

• To assess the predictive value of admission C-reactive protein (CRP) levels for 30-day major adverse cardiovascular events (MACE) in patients with acute myocardial infarction (AMI).

Main Methods:

• Prospective observational cohort study of 200 AMI patients over 12 months.
• Patients stratified into CRP groups: <5 mg/L, 5-10 mg/L, and >10 mg/L.
• Statistical analysis included logistic regression to identify independent predictors of 30-day MACE.

Main Results:

• Elevated CRP levels (>10 mg/L) were significantly associated with higher 30-day MACE incidence (42.2%) compared to moderate (24.7%) and low (8.6%) CRP groups (p < 0.001).
• Admission CRP was an independent predictor of 30-day MACE (adjusted OR: 1.18 per 1 mg/L increase, p < 0.001).
• Other independent predictors included age, troponin, and time to hospital admission.

Conclusions:

• Admission CRP levels are a strong independent predictor of short-term adverse outcomes in AMI patients.
• CRP can aid in early risk stratification and guide management decisions for AMI patients.
• Utilizing CRP levels can improve patient management strategies following acute myocardial infarction.